The feature of the NAFLD serum bile acid profile is the elevated bile acid production and the increase in the FXR antagonistic DCA with the decrease in the agonistic CDCA [17]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.